 
                                                                                                    08/16/2023
                                            “When you have an option that can delay the need for open-heart surgery and can offer relief … we’re finding a significant number of patients would opt for that.”
- Dr. Ahmad Masri, director of the hypertrophic cardiomyopathy center at OHSU                                        
As Bristol Myers Squibb works to build Camzyos into a blockbuster drug, it has propped up an algorithm designed to help find more people who are affected by the heart condition it treats.
 
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                         
   
   
   
   
     
   
   
  